Objective: To identify possible electroencephalographic (EEG) markers of donepezil's effect on cortical activity in young, healthy adult volunteers at the group level. Methods: Thirty subjects were administered a daily dose of either 5. mg donepezil or placebo for 15. days in a double-blind, randomized, cross-over trial. The electroencephalogram during an auditory oddball paradigm was recorded from 58 scalp electrodes. Current source density (CSD) transformations were applied to EEG epochs. The event-related potential (ERP), inter-trial coherence (ITC: the phase consistency of the EEG spectrum) and event-related spectral perturbation (ERSP: the EEG power spectrum relative to the baseline) were calculated for the target (oddball) stimuli. Re...
RATIONALE: Both psychotropic drugs and mental disorders have typical signatures in quantitative elec...
RATIONALE: Olanzapine is an atypical antipsychotic drug with a more favourable safety profile than t...
Neuroimaging studies of cholinesterase inhibitor (ChEI) treatment in Alzheimer's disease (AD) have s...
To identify possible electroencephalographic (EEG) markers of donepezil's effect on cortical activit...
Rising life expectancies coupled with an increasing awareness of age-related cognitive decline have ...
BACKGROUND Latency of P300 subcomponent of event-related potentials (ERPs) increases in Alzheimer di...
Background: In previous research we identified ERP and behavioural features associated with memory t...
Attentional selection in the context of goal-directed behavior involves top-down modulation to enhan...
Objective: There is an increasing interest in the effects of the acetylcholinesterase inhibitors (AC...
Acetylcholinesterase inhibitors (AChEI) such as donepezil act in mild Alzheimer’s disease (AD) by in...
Objective: The acute nootropic potential of donepezil in young healthy volunteers has not been adequ...
Alzheimer's disease dementia (ADD) is the most diffuse neurodegenerative disorder belonging to mild ...
Abstract Background Translational research in Alzheimer’s disease (AD) pathology provides evidence t...
Twenty patients affected with probable mild-to-moderate Alzheimer's disease (AD; NINCDS-ADRDA criter...
Study Objective: Examine the effects of donepezil on sleep and rapid eye movement (REM) sleep electr...
RATIONALE: Both psychotropic drugs and mental disorders have typical signatures in quantitative elec...
RATIONALE: Olanzapine is an atypical antipsychotic drug with a more favourable safety profile than t...
Neuroimaging studies of cholinesterase inhibitor (ChEI) treatment in Alzheimer's disease (AD) have s...
To identify possible electroencephalographic (EEG) markers of donepezil's effect on cortical activit...
Rising life expectancies coupled with an increasing awareness of age-related cognitive decline have ...
BACKGROUND Latency of P300 subcomponent of event-related potentials (ERPs) increases in Alzheimer di...
Background: In previous research we identified ERP and behavioural features associated with memory t...
Attentional selection in the context of goal-directed behavior involves top-down modulation to enhan...
Objective: There is an increasing interest in the effects of the acetylcholinesterase inhibitors (AC...
Acetylcholinesterase inhibitors (AChEI) such as donepezil act in mild Alzheimer’s disease (AD) by in...
Objective: The acute nootropic potential of donepezil in young healthy volunteers has not been adequ...
Alzheimer's disease dementia (ADD) is the most diffuse neurodegenerative disorder belonging to mild ...
Abstract Background Translational research in Alzheimer’s disease (AD) pathology provides evidence t...
Twenty patients affected with probable mild-to-moderate Alzheimer's disease (AD; NINCDS-ADRDA criter...
Study Objective: Examine the effects of donepezil on sleep and rapid eye movement (REM) sleep electr...
RATIONALE: Both psychotropic drugs and mental disorders have typical signatures in quantitative elec...
RATIONALE: Olanzapine is an atypical antipsychotic drug with a more favourable safety profile than t...
Neuroimaging studies of cholinesterase inhibitor (ChEI) treatment in Alzheimer's disease (AD) have s...